BioCentury
ARTICLE | Clinical News

BaroFeron: Phase I started

June 23, 2008 7:00 AM UTC

BaroFold began a double-blind, dose-escalation, Dutch Phase I trial in up to 60 volunteers. Avecia Biologics Ltd. (Manchester, U.K.) will manufacture the product for BaroFold. ...